KORU Medical Systems, Inc.
KORU Medical Systems, Inc. (KRMD) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
krmd · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for KORU Medical Systems, Inc. (KRMD) measures how much investors pay for each dollar of the company's trailing earnings. KRMD's current PE ratio of N/A is calculated by dividing its stock price of $3.98 by its TTM earnings per share of -$0.05.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2007 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 11 fiscal years · Front-end computedMinQ1 · 25%10.9x
MedianQ3 · 75%448.7x
Max
At N/A, KRMD's current P/E is lower than in 0% of its annual fiscal year readings over the past 11 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
KORU Medical Systems, Inc.You KRMD | $183M | N/A | — | -$0.05 |
 Vyome Holdings, Inc. HIND | $12M | N/A | — | -$4.75 |
 InfuSystem Holdings, Inc. INFU | $183M | 27.96x | — | $0.32 |
 MaxCyte, Inc. MXCT | $126M | N/A | — | -$0.42 |
 Nyxoah S.A. NYXH | $56M | N/A | — | -$2.36 |
 OraSure Technologies, Inc. OSUR | $285M | N/A | — | -$0.94 |
 Prenetics Global Limited PRE | $348M | N/A | — | -$2.68 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.06 | — | |
2024-12-31 FY2024 | — | $-0.13 | — | |
2023-12-31 FY2023 | — | $-0.30 | — | |
2022-12-31 FY2022 | — | $-0.19 | — | |
2021-12-31 FY2021 | — | $-0.10 | — | |
2020-12-31 FY2020 | — | $-0.03 | — | |
2019-12-31 FY2019 | 448.70x | $0.01 | +549.4% | |
2018-12-31 FY2018 | 69.09x | $0.02 | +86.9% | |
2017-12-31 FY2017 | 36.97x | $0.03 | — | |
2017-02-28 FY2017 | — | $-0.01 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for KORU Medical Systems, Inc. (KRMD) measures how much investors pay for each dollar of the company's trailing earnings. KRMD's current PE ratio of N/A is calculated by dividing its stock price of $3.98 by its TTM earnings per share of -$0.05.
Frequently asked questions
KRMD pe ratio · 6 questionsKRMD's current PE ratio is N/A as of 2026-06-08, based on a stock price of $3.98 and TTM EPS of -$0.05. Data sourced from Financial Modeling Prep via KRMD's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · KORU Medical Systems, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08